Saturday, October 3, 2026

USD/CNH Is 6% Down In The Last 21 Sessions

USD/CNH Is 6% Down In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 6% for the last 21 sessions. At 06:06 EST on Monday, 27 March, USD/CNH (USDCNH) is $6.88.

USD/CNH's yearly highs and lows, it's 0.27% up from its 52-week low and 0.094% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/CNH's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy portrays four-day downtrend near 130.50 with eyes on Japan/us inflation clues. According to FXStreet on Monday, 27 March, "Should the inflation numbers print strong outcomes, the greenback has scope for recovery and can allow the USD/JPY to pare recent losses.", "It should be noted that Friday's mixed details of the US Durable Goods Orders and Purchasing Managers' Index for February and March respectively joined the hawkish Fed speak to trigger the USD/JPY pair's corrective bounce off the multi-day low."
  • Usd/jpy: neutral view amidst global banking turmoil – morgan stanley. According to FXStreet on Monday, 27 March, "Analysts at Morgan Stanley shift their view on the USD/JPY pair to neutral from their previous long recommendation.", "With the risk of the market pricing in further policy convergence, we close our long USD/JPY position and turn neutral until things become much clearer."
  • Usd/jpy price analysis: bulls find support at 130.00 amid banking support measures. According to FXStreet on Monday, 27 March, "The USD/JPY experienced a sharp rebound after finding support at the 130.00 mark. ", "A strong reversal in price or sudden surge in US Dollar demand could propel the USD/JPY to the March high of 138.00, a key psychological level."

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com